✦ LIBER ✦

PP-7-6 Dose dense epirubicin (E) and paclitaxel (P) with G-CSF in metastatic breast cancer (MBC)

✍ Scribed by J. Nortier; J. Wils; F. Erdkamp; R. Lalisang; J. Wals; H. Hillen; G. Blijham

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin and paclitaxel with G-CSF sup

✍ R. I. Lalisang; F. L. G. Erdkamp; C. J. Rodenburg; C. T. A. M. Knibbeler-van Ros 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 210 KB

122 O - A phase I trial of epirubicin (E

✍ R. Salyadori; A. Mlchelotti; E. Baldini; A. Gennari; C. Tibaldi; A. Tognani; P.G 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 167 KB

128 P - Epirubicin intermediate dose plu

✍ G. Trotti; M. Airoldi; G. Reguzzoni; E. Caronno; M.C. Giorgetti; E. Piatto; G. S 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 144 KB

PP-7-4 Phase lll study of taxol® (paclit

✍ M.Tubiana Hulin; G. Catimel; J. Bonneterre; J.A. Soares; M. Chazard 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 150 KB

PP-7-7 Taxol. (paclitaxel), epirubicin a

✍ J.-M. Nabholtz; K. Khoo; T. Al-Tweigeri; M. Smylie; D. Dudgeon; O. Keller; J. Fo 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB

PP-7-5 phase II study of paclitaxel (P)

✍ Ch. Thomssen; H.-J. Lück; A. du Bois; B. Lisboa; M. Untch; G. Köhler; D. Hecker; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB